Elevance Health Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELV research report →
About the company
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals.
- CEO
- Gail Koziara Boudreaux
- IPO
- 2001
- Employees
- 104,200
- HQ
- Indianapolis, IN, US
Price Chart
- Market Cap
- $86.39B
- P/E
- 16.73
- P/S
- 0.43
- P/B
- 2.00
- EV/EBITDA
- 12.18
- Div Yield
- 1.72%
- Gross Margin
- 23.16%
- Op Margin
- 3.81%
- Net Margin
- 2.62%
- ROE
- 11.95%
- ROIC
- 7.91%
- Revenue
- $199.13B · 12.62%
- Net Income
- $5.66B · -5.32%
- EPS
- $25.18 · -2.44%
- Op Income
- $8.11B
- FCF YoY
- -30.27%
- 52W High
- $426.98
- 52W Low
- $273.71
- 50D MA
- $371.61
- 200D MA
- $340.50
- Beta
- 0.68
- Avg Volume
- 1.68M
Get TickerSpark's AI analysis on ELV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 12, 26 | Penczek Ronald W | sell | 369 |
| Jun 11, 26 | Dixon Robert L JR | sell | 151 |
| May 19, 26 | Penczek Ronald W | other | 877 |
| May 19, 26 | Penczek Ronald W | other | 654 |
| May 19, 26 | Penczek Ronald W | sell | 1,531 |
| May 19, 26 | Penczek Ronald W | other | 654 |
| May 19, 26 | Penczek Ronald W | other | 877 |
| May 13, 26 | STRABLE-SOETHOUT DEANNA D | other | 563 |
| May 13, 26 | SCHULMAN AMY W | other | 563 |
| May 13, 26 | Schneider Ryan M. | other | 563 |
Our ELV coverage
Recent articles, reports, and earnings notes.
Elevance Health (ELV): 2026 Reset, 2027 Upside
Elevance Health is a high-quality managed care franchise taking a deliberate earnings reset in 2026 to protect long-term margins. The stock looks reasonably valued versus its earnings power, with a path to stronger growth in 2027.
Managed care's rebound looks real, but the easy bull case is early
Health insurers are finally showing signs that the medical-cost spike is easing, but that is not the same thing as a clean, durable margin reset across the group. The better trade still looks selective: some operators are stabilizing, while others remain too expensive or too exposed to unresolved Medicare Advantage and Medicaid pressure.
Elevance Health Inc. (ELV) gains on deep earnings beat
Elevance Health Inc. (ELV) gained after a solid earnings beat and higher full-year guidance, but the deeper story is in the details: Medicare Advantage improved, Medicaid pressure persisted, and nonrecurring investment income boosted results. Here’s a full breakdown of what drove the quarter and what still matters.
Want a deeper read on ELV?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.